---
domain: health
tags: [harmonism, wheel-of-harmony, wheel-of-health, health, cancer, prevention, protocol, metabolic, inflammation, detox, screening, fasting, autophagy]
content_layer: bridge
doctrinal_status: clear
breadth: full
depth: developed
craft: clean
published: "2026-05-17"
---
# Cancer Prevention — Harmonism Protocol

*Part of the [[Wheel of Health]]. See also: [[Inflammation-Chronic-Disease|Inflammation & Chronic Disease]], [[Purification]], [[Health-Longevity-Biggest-Levers|Biggest Levers]], [[Monitor]].*

---

## Harmonism Position on Cancer

Cancer is not random. The dominant narrative — cancer as genetic lottery, as pure bad luck in cell division — captures one dimension while obscuring the deeper, more actionable truth: **cancer is fundamentally a disease of terrain.** Mutations occur constantly in every living body. The relevant question is not whether mutations happen but whether the body's surveillance and repair systems can contain them. When the terrain is degraded — when inflammation becomes chronic, insulin remains elevated, the immune system atrophies, oxygen delivery fails, and detoxification systems are overwhelmed — mutations that would normally be recognized and eliminated are instead permitted to establish, proliferate, and metastasize. The cell becomes cancerous not merely because of its mutations but because the body has lost the capacity to defend against them.

This reframing carries enormous practical weight. If cancer is purely genetic — the bad-luck narrative — then prevention collapses to screening and, for high-risk individuals, prophylactic surgery. The individual's actions mean little. If cancer is primarily a disease of terrain, with genetics as one risk modifier among many, then **prevention becomes something the sovereign practitioner can actively pursue** through the metabolic, immunological, and lifestyle interventions that the [[Wheel of Health]] structures.

Harmonism does not deny genetic risk — BRCA mutations, Lynch syndrome, Li-Fraumeni syndrome genuinely increase susceptibility. But it holds that **terrain determines manifestation.** A BRCA carrier with optimal metabolic health, robust immune surveillance, low chronic inflammation, excellent sleep, and minimal toxic burden inhabits a fundamentally different risk landscape than a BRCA carrier with metabolic syndrome, fragmented sleep, and high inflammatory markers. Genetics loads the gun; terrain pulls the trigger. The protocol below addresses terrain. Genetic risk management (screening, specialist consultation, potential prophylactic intervention) is a complementary and sometimes essential track, but not the whole story.

---

## The Metabolic Theory of Cancer

Conventional oncology rests on the somatic mutation theory (SMT): cancer arises from accumulated DNA mutations that progressively transform a normal cell into a malignant one. This theory, dominant for decades, structures the approach to cancer: genetic testing, targeted molecular therapies, and chemotherapy.

A growing and increasingly rigorous body of evidence articulates a complementary perspective: the **metabolic theory of cancer**, most precisely formulated by Thomas Seyfried (building on Otto Warburg's foundational observations from the 1930s). The core proposition is direct: **cancer is fundamentally a metabolic disease characterized by damaged mitochondria.** Cancer cells lose the capacity for efficient oxidative phosphorylation — the normal, oxygen-dependent energy pathway — and become dependent on fermentation: the glycolytic pathway that burns glucose and glutamine for fuel regardless of oxygen availability. This is the Warburg effect.

The practical implications cascade through every aspect of prevention:

**Glucose and insulin are fuel for cancer.** If cancer cells are metabolically dependent on glucose, then chronic hyperglycemia and hyperinsulinemia create a permissive metabolic environment. Insulin itself functions as a growth factor through IGF-1 signaling — promoting cell proliferation, inhibiting apoptosis, and directly fueling the cancer progression pipeline. The connection between metabolic syndrome and cancer risk is not speculative but measurable.

**Ketosis creates metabolic asymmetry.** When the body shifts from glucose to ketone metabolism — through fasting, ketogenic diet, or sustained movement — healthy cells with functional mitochondria adapt readily. Cancer cells cannot efficiently utilize ketones. This creates a **metabolic differential that the immune system can exploit.** Periodic fasting and metabolic flexibility are therefore not merely weight management tools but cancer prevention strategies at the cellular level.

**Mitochondrial integrity is cancer prevention.** Everything that damages mitochondria — chronic oxidative stress, environmental toxins, micronutrient depletion (CoQ10, magnesium, B vitamins), chronic inflammation — increases the probability of metabolic collapse toward fermentation. Conversely, everything that preserves mitochondrial function — consistent movement, intermittent fasting, cold exposure, micronutrient sufficiency — is directly cancer-protective.

Harmonism does not choose between mutation theory and metabolic theory — it recognizes their interdependence. Damaged mitochondria create genomic instability; accumulated mutations further impair mitochondrial function. The practical convergence is clear: **the same interventions that restore the metabolic terrain also reduce mutation frequency and enhance repair capacity.** The choice between two theories dissolves when you address the terrain itself.

---

## The Six Pillars of Cancer Prevention

### 1. Metabolic Health — Starve the Terrain

The single most consequential cancer prevention strategy is metabolic health: normal fasting glucose, low fasting insulin, low visceral fat, and intact insulin sensitivity. This is not a cancer-specific intervention — it is the same metabolic foundation that prevents diabetes, cardiovascular disease, and neurodegeneration. Cancer prevention is metabolic prevention viewed through a specific lens.

**Key targets:**

*Fasting insulin below 5 µIU/mL.* This is the gold standard marker for metabolic cancer risk. Elevated insulin drives IGF-1, promotes cell proliferation, inhibits apoptosis, and creates a growth-permissive environment. Achieving this requires the dietary and movement interventions described in [[The First 90 Days]] and [[Nutrition]].

*Fasting glucose 70–85 mg/dL, HbA1c below 5.3%.* Chronic hyperglycemia fuels the Warburg effect directly.

*Visceral fat minimized.* DEXA scan or waist-to-hip ratio as proxies. Visceral fat is not merely a marker of metabolic dysfunction — it actively produces inflammatory cytokines, aromatase (converting testosterone to estrogen, driving hormone-sensitive cancers), and adipokines that promote angiogenesis (new blood vessel formation that tumors need to grow).

*Periodic fasting.* Time-restricted eating (daily 16:8 or 14:10) as baseline. Quarterly extended fasts (24–72 hours) for autophagy activation. Autophagy — the cellular recycling process triggered by nutrient deprivation — clears damaged mitochondria (mitophagy), misfolded proteins, and pre-cancerous cells. Valter Longo's research on fasting-mimicking diets demonstrates measurable reduction in IGF-1, inflammatory markers, and cancer biomarkers with periodic 5-day fasting cycles.

*Glucose-Ketone Index (GKI) as metabolic cancer marker.* The GKI is the single most actionable metric for metabolic cancer prevention and therapeutic fasting. Calculation: blood glucose (mg/dL) ÷ 18 ÷ blood ketone level (mmol/L). Target ranges: GKI 6–9 for general metabolic health; GKI 1–3 for therapeutic cancer protocol (blood glucose 60–85 mg/dL, blood ketones 2–4 mmol/L); GKI under 1.0 for maximum metabolic pressure during supervised therapeutic fasting. A dual blood glucose/ketone meter provides the necessary data — this is [[Monitor]] applied to metabolic terrain at its most precise. Sustained GKI in the 1–3 range creates the metabolic differential that makes cancer cells vulnerable: healthy cells with functional mitochondria adapt to ketone metabolism; cancer cells dependent on fermentation cannot.

### 2. Anti-Inflammatory Terrain

Chronic inflammation creates the microenvironment in which cancer initiates and progresses. The full anti-inflammatory protocol is detailed in [[Inflammation-Chronic-Disease]]. The cancer-specific emphasis:

*NF-κB suppression.* NF-κB is the master inflammatory transcription factor, and it is constitutively activated in many cancer types. Curcumin, sulforaphane, omega-3 fatty acids, and resveratrol all modulate NF-κB signaling.

*Nrf2 activation.* The Nrf2 pathway controls the body's antioxidant and detoxification response. Activating Nrf2 upregulates glutathione, SOD, and catalase — the body's own defense against oxidative DNA damage. Sulforaphane (from broccoli sprouts) is the most potent known natural Nrf2 activator. Daily consumption of broccoli sprouts (30g) or supplementation with sulforaphane extract provides meaningful Nrf2 induction.

*Resolving inflammation, not just suppressing it.* The body produces specialized pro-resolving mediators (resolvins, protectins, maresins) from omega-3 fatty acids. These actively resolve inflammation rather than merely blocking the inflammatory signal. Adequate omega-3 intake (2–4g EPA/DHA daily) ensures the substrate for resolution is available.

### 3. Immune Surveillance — The Body's Anti-Cancer System

The immune system identifies and destroys abnormal cells constantly — the process called immune surveillance. Natural killer (NK) cells, cytotoxic T cells, and macrophages patrol for cells displaying aberrant surface markers. Cancer only establishes itself when this surveillance fails.

**What suppresses immune surveillance:**

Chronic stress (cortisol suppresses NK cell activity). Sleep deprivation (a single night of restricted sleep reduces NK cell activity by up to 70%, per Matthew Walker's research). Vitamin D deficiency (vitamin D is a potent immune modulator — low levels correlate with increased cancer risk across multiple types). Chronic inflammation (paradoxically, chronic immune activation leads to immune exhaustion, reducing the capacity for targeted anti-cancer responses). Gut dysbiosis (70–80% of immune tissue is in the gut — a compromised microbiome impairs systemic immune function).

**What enhances immune surveillance:**

*Sleep.* 7–9 hours, consistent timing. Non-negotiable. The most powerful immune-supportive intervention available.

*Vitamin D.* Target blood level: 50–70 ng/mL (125–175 nmol/L). Strong epidemiological evidence links higher vitamin D levels with reduced incidence of colorectal, breast, prostate, and several other cancers. Dose to blood level — typically 4,000–6,000 IU daily, tested and adjusted.

*Medicinal mushrooms.* Reishi (Ganoderma lucidum), turkey tail (Trametes versicolor), chaga (Inonotus obliquus), and maitake (Grifola frondosa) have demonstrated immunomodulatory effects in human research — specifically, enhancement of NK cell activity and T-cell function. The Taoist tonic herbalism tradition uses reishi as the supreme Shen tonic and immune regulator. Turkey tail (PSK/PSP polysaccharides) has been used as an adjunctive cancer therapy in Japan for decades.

*Exercise.* Moderate-intensity exercise acutely increases NK cell mobilization and cytotoxicity. Regular exercise creates a sustained improvement in immune surveillance. The key word is moderate — overtraining suppresses immunity.

*Cold exposure.* Brief cold water immersion increases circulating NK cells and other immune parameters. Hormetic stress primes the immune system.

### 4. Detoxification — Reduce the Carcinogen Load

Environmental carcinogens are a modifiable risk factor. The body accumulates heavy metals, persistent organic pollutants (POPs), pesticide residues, and endocrine disruptors — many of which are directly genotoxic (causing DNA damage) or epigenotoxic (altering gene expression in ways that promote cancer).

**Priority carcinogens to reduce:**

*Heavy metals:* Mercury (from dental amalgams, large predatory fish), lead (from old paint, contaminated water, some supplements), cadmium (from cigarettes, contaminated soil, some cocoa), arsenic (from rice, groundwater). Testing: a provoked heavy metal urine test (with DMSA challenge) provides the most accurate assessment of body burden. Chelation with DMSA or EDTA under practitioner guidance for significant loads. Daily mitigation: chlorella, cilantro, selenium, NAC (supports glutathione — the body's primary heavy metal detoxifier).

*Endocrine disruptors:* BPA and BPS (from plastic containers, receipts, can linings), phthalates (from fragrances, soft plastics, personal care products), PFAS (from non-stick cookware, waterproof fabrics). These disrupt estrogen, testosterone, and thyroid signaling — directly relevant to hormone-sensitive cancers (breast, prostate, ovarian, endometrial). Mitigation: glass and stainless steel food storage, natural personal care products, cast iron or stainless steel cookware, water filtration.

*Pesticides:* Glyphosate (the most widely used herbicide globally) has been classified as a "probable human carcinogen" by the WHO's IARC. Organophosphates and organochlorines have known endocrine-disrupting and genotoxic effects. Mitigation: organic produce for the "dirty dozen" highest-pesticide crops at minimum, broad organic diet where economically feasible.

*Sauna for detox:* Regular sauna use mobilizes fat-soluble toxins through sweat — a significant excretion pathway for heavy metals and POPs. The Hubbard protocol (sauna combined with niacin and exercise) was originally developed for detoxifying drug residues and has been adapted for environmental toxin clearance. 3–5 sauna sessions per week is the evidence-supported frequency. See [[Purification]] and [[Recovery]] for detailed protocols.

### 5. Anti-Cancer Nutrition — Specific Foods and Substances

Beyond the general anti-inflammatory framework, specific foods and compounds have demonstrated anti-cancer activity in human research:

*Cruciferous vegetables* — sulforaphane (from broccoli, broccoli sprouts, Brussels sprouts, kale, cauliflower) induces phase 2 detoxification enzymes, activates Nrf2, inhibits histone deacetylase (an epigenetic mechanism exploited by cancer cells), and promotes apoptosis in cancer cell lines. Broccoli sprouts contain 20–100x more sulforaphane precursor than mature broccoli.

*Green tea* — EGCG (epigallocatechin gallate) inhibits angiogenesis, induces apoptosis, and modulates multiple signaling pathways involved in cancer progression. 3–5 cups of high-quality green tea daily or supplemental EGCG (400–800mg).

*Turmeric/curcumin* — NF-κB inhibition, COX-2 inhibition, angiogenesis inhibition, apoptosis induction. Bioavailable form (phytosomal or with piperine), 500–1000mg daily.

*Garlic and alliums* — allicin and diallyl sulfide activate detoxification enzymes and have demonstrated anti-cancer effects in epidemiological studies (particularly colorectal and stomach cancer). Crush garlic and wait 10 minutes before cooking to allow allicin formation.

*Berries* — ellagic acid (raspberries, strawberries, pomegranates) and anthocyanins (blueberries, blackberries) have anti-proliferative and anti-angiogenic effects. Daily consumption.

*Fermented foods* — butyrate (produced by gut bacteria fermenting fiber) has direct anti-cancer effects on colonocytes. Maintaining a diverse, fiber-fed microbiome is colorectal cancer prevention.

*Modified citrus pectin* — binds galectin-3 (a protein involved in cancer cell adhesion and metastasis). Emerging evidence in prostate cancer specifically.

### 6. Screening and Genetic Risk Management

Sovereign health does not reject conventional screening — it incorporates it as one dimension of Monitor. Early detection dramatically improves outcomes for most cancer types.

**Evidence-supported screening schedule (adjust for personal risk):**

*Colonoscopy* — beginning at age 45 (earlier with family history or symptoms). Every 10 years if normal. Colorectal cancer is one of the most preventable cancers through screening.

*Skin check* — annual dermatologist examination for melanoma, more frequently with risk factors (fair skin, history of sunburns, many moles, family history).

*Cervical screening* — Pap smear + HPV testing per guidelines (typically every 3–5 years from age 21–65).

*Breast screening* — mammography timeline and frequency should be discussed individually, balancing detection benefit against false positive risk. Those with BRCA mutations or strong family history require enhanced screening (MRI + mammography).

*Prostate* — PSA testing combined with clinical context (not PSA alone, which has high false positive rates). Multiparametric MRI for further investigation when PSA is elevated or rising. See [[Prostate-Health]] for the detailed prostate protocol.

*Full-body MRI* — an emerging screening modality that can detect cancers before symptoms appear. Currently expensive and not covered by most insurance, but increasingly available. Consider annually for high-risk individuals.

*Liquid biopsy* — circulating tumor DNA (ctDNA) tests like Grail's Galleri can screen for 50+ cancer types from a single blood draw. Currently best as a complement to traditional screening, not a replacement. The technology is advancing rapidly.

**For high-risk genetics (BRCA, Lynch syndrome, etc.):**

Genetic testing is essential for anyone with strong family history of breast, ovarian, colorectal, or other hereditary cancers. A confirmed mutation changes the screening and prevention strategy materially. For BRCA carriers specifically: enhanced breast surveillance (MRI + mammography starting at 25–30), risk-reducing salpingo-oophorectomy (the gold standard for ovarian cancer risk reduction in BRCA carriers, typically recommended after completing childbearing), and specialist oncology follow-up. The terrain interventions above still apply — they reduce risk even in the context of elevated genetic susceptibility — but they do not substitute for risk-appropriate medical management.

---

## Advanced Integrative Technologies

Harmonist practice integrates the cutting-edge protocols developed within the Taoist tonic herbalism lineage (specifically the work of Truth Calkins) and within biophysical medicine. These interventions operate at the frontier between validated and experimental — they have clinical observation, practitioner experience, and varying degrees of research support. The sovereign practitioner evaluates them as part of a comprehensive approach, not as standalone silver bullets.

### CellSonic VIPP

[[Cellsonic|CellSonic VIPP]] (Very Intense Pressure Pulses) is an extracorporeal shockwave therapy originally developed to shatter kidney stones, evolved into a broader therapeutic platform. The mechanism is biophysical rather than chemical: pressure waves create mechanotransduction (triggering cellular repair), cavitation (physically disrupting calcifications, fibrotic tissue, and tumor masses), neovascularization (stimulating new blood vessel formation), and cellular voltage restoration (resetting membrane potential from the depressed millivolt range characteristic of diseased cells back to the healthy -70 to -90mV range).

In the cancer context, CellSonic VIPP physically disrupts tumor cell membranes, restores cellular voltage in the tumor microenvironment, and triggers immune recognition of previously shielded cancer cells. Clinical integration of CellSonic in European oncology settings has reported dramatic improvements in outcomes. The protocol involves direct treatment of all identified tumor sites plus regular spinal treatments for systemic immune activation.

CellSonic is the most promising biophysical cancer intervention in Harmonist assessment — it operates through physics rather than chemistry, works fast on late-stage tumors, and complements all other interventions. It is not a standalone cure but a powerful component in a comprehensive program. See [[Cellsonic]] for the full technical profile.

### Rife Frequency Technology

Frequency-based therapy uses specific electromagnetic frequencies to target pathological organisms and dysfunctional cells. The historical lineage traces to Royal Rife's original research in the 1930s. Modern devices deliver targeted frequencies that resonate with the molecular structure of pathogens and cancer cells, creating mechanical disruption at the cellular level.

The highest-powered Rife devices deliver the strongest therapeutic signal for cancer and serious infections. The treatment involves extended daily sessions with specific frequency programs targeting the cancer type. Rife therapy is most effective as part of a comprehensive protocol — it addresses the pathogenic and cellular dimension but does not fix the metabolic terrain that permitted cancer in the first place.

### Hydrogen Therapy

Molecular hydrogen (H₂) is emerging as a significant therapeutic agent, with Japanese research approximately 20 years ahead of Western investigation. Hydrogen acts as a selective antioxidant — it neutralizes the most damaging reactive oxygen species (hydroxyl radical, peroxynitrite) without interfering with the beneficial signaling ROS that the immune system uses. It upregulates the Nrf2 pathway, boosting endogenous antioxidant production (glutathione, SOD).

*Protocol:* Hydrogen-rich water produced by a high-quality electrolysis generator (using zero-TDS water), consumed fresh within minutes of production (hydrogen dissipates rapidly). Two pitchers in the morning, spaced 3 hours apart. Simultaneous hydrogen gas inhalation through nasal cannula amplifies the effect. In the cancer context, hydrogen therapy provides systemic antioxidant support, reduces inflammation, and supports mitochondrial function — addressing the metabolic terrain while other interventions target the tumor directly.

### The Press-Pulse Strategy — Metabolic Therapy in Active Cancer

For active cancer, the metabolic theory yields a specific therapeutic protocol: the press-pulse strategy, formulated by Thomas Seyfried. The logic is direct. Cancer cells depend on glucose and glutamine for energy. Sustained ketosis (the "press") restricts glucose availability system-wide, creating chronic metabolic stress on cancer cells while healthy cells adapt to ketone metabolism. Timed fasting (the "pulse") delivers acute metabolic shocks — 4–5 day liquid fasts or fasting-mimicking diet cycles timed to coincide with any conventional treatment. When chemotherapy or radiation is delivered on day 4–5 of a fast — at peak ketosis, when GKI is in the 1–3 range — the metabolic vulnerability of cancer cells is maximally exposed. Clinical observation and Seyfried's research indicate that chemotherapy delivered during deep ketosis can achieve equal or superior efficacy at a fraction of the standard dosage (as low as one-quarter of conventional dose), with dramatically reduced side effects to healthy tissue.

Hyperbaric oxygen (HBOT) at 2.5–2.75 ATA exploits the same metabolic vulnerability from the oxygen side. Cancer cells dependent on glycolysis cannot handle the increased oxygen tension; healthy cells with functional mitochondria thrive in it. HBOT administered at the end of a short fast — when ketones are elevated and glucose is suppressed — creates a dual metabolic-oxidative assault on cancer cells with negligible side effects to healthy tissue. The combination of sustained ketosis, timed fasting, reduced-dose chemotherapy, and HBOT represents the most coherent metabolic cancer therapy currently available.

This is not an alternative to conventional treatment but a framework for optimizing it. The sovereign practitioner facing cancer does not choose between metabolic therapy and oncology — they integrate metabolic terrain optimization into whatever treatment protocol their medical team recommends, enhancing efficacy and reducing collateral damage.

### Oxygen and Oxidative Therapies

Oxidative therapies — including EBOO (Extracorporeal Blood Oxygenation and Ozonation), hydrogen peroxide protocols, and hyperbaric oxygen — exploit cancer cells' metabolic vulnerability. Cancer cells, dependent on glycolysis (the Warburg effect), are less able to handle increased oxygen tension than healthy cells with functional mitochondria. EBOO is a particularly advanced modality that oxygenates and ozonates the blood extracorporeally, clearing pathogenic load and restoring oxygen-carrying capacity.

### The Comprehensive Cancer Supplement Stack

The following supplements form the advanced cancer-specific layer, drawn from the tonic herbalism lineage and validated through clinical observation. They are additions to, not replacements for, the foundational anti-inflammatory and immune-support stack described above.

*AHCC (Active Hexose Correlated Compound)* — a mushroom-derived immunomodulator. Enhances NK cell activity, T-cell function, and dendritic cell maturation. Extensively researched in Japan for cancer adjunctive therapy. Sublingual administration (hold in mouth, dissolve, hold under tongue) improves bioavailability. Daily use in any cancer prevention or treatment protocol.

*Modified Citrus Pectin* — blocks galectin-3, a protein critically involved in cancer cell adhesion, metastasis, and immune evasion. Also functions as a gentle heavy metal chelator. Particularly well-evidenced for prostate cancer. Two doses daily in cancer protocol.

*IP6 (Inositol Hexaphosphate)* — with inositol. Enhances NK cell activity, inhibits cancer cell proliferation, and supports healthy cell differentiation. Researched specifically for colon and other cancers. Two to three doses daily in cancer protocol.

*Ellagic Acid / Raspberry Seed Powder* — Red raspberry seed powder provides concentrated ellagic acid, a polyphenol with potent anti-proliferative, pro-apoptotic, and anti-angiogenic properties. The administration method matters: dry-crush the powder in a mortar and pestle for 5 minutes, take 2 teaspoons in mouth, chew with saliva until liquid, swish for 10–20 minutes, then swallow. This oral absorption method bypasses the poor water solubility of ellagic acid. Ellagic acid also lowers blood sugar, supports stem cell production, and has broad anti-cancer activity. The combination of IP6 + ellagic acid + ketogenic diet forms the core of the supplement-based cancer protocol.

*Medicinal mushroom complex* — Reishi, turkey tail (PSK/PSP), chaga, maitake, cordyceps, and phellinus. Each contributes distinct immunomodulatory polysaccharides. In combination, they provide broad-spectrum immune potentiation that supports the body's anti-cancer surveillance.

*High-dose melatonin* — 20mg at bedtime (far above the 0.5–3mg typical for sleep). At therapeutic doses, melatonin functions as a potent antioxidant and has demonstrated anti-cancer properties in multiple cancer types — anti-proliferative, pro-apoptotic, and anti-angiogenic. This is a cancer-specific intervention, not a sleep supplement.

*Aged Garlic Extract* — liquid form preferred for bioavailability. Aged garlic extract (AGE) delivers organosulfur compounds (S-allylcysteine, S-allylmercaptocysteine) that have demonstrated anti-proliferative, anti-angiogenic, and immune-potentiating effects across multiple cancer types. AGE is distinct from raw garlic supplementation — the aging process converts unstable allicin into stable, bioavailable compounds with higher therapeutic consistency.

*Pau d'Arco (Taheebo)* — both as tea and as enema solution. Contains lapachol and beta-lapachone, which have demonstrated anti-cancer and anti-fungal activity. The enema application delivers therapeutic compounds directly to the colonic mucosa — particularly relevant for colorectal cancer prevention and treatment.

> [!warning] **Critical contraindication: NAC and glutathione boosters during active cancer.** N-acetylcysteine (NAC) and direct glutathione supplementation — otherwise excellent detoxification support — are contraindicated in active cancer. Cancer cells exploit the glutathione antioxidant system for their own survival, using it to protect themselves from oxidative damage and resist chemotherapy. Supplementing NAC or glutathione during active cancer may inadvertently shield cancer cells from the immune system's oxidative attack and from the oxidative mechanisms of chemotherapy. This is a case where a substance beneficial in prevention becomes harmful in treatment — a distinction the [[Monitor]] must track.

---

## The Integration Principle

Cancer prevention is not a separate health project grafted onto life. It is the **natural structural consequence** of the [[Wheel of Health]] rotating in proper alignment: metabolic health sustained and inflammation resolved; immune surveillance kept vigilant while toxic load is drawn down; sleep protected, movement consistent; the body nourished with real food and returned to the rhythms of natural order. The cancer-specific interventions — periodic fasting for autophagy activation, medicinal mushrooms for immune potentiation, sulforaphane for Nrf2 activation, appropriate screening — layer upon a foundation that is already cancer-protective by nature.

The sovereign practitioner does not wait for disease to manifest before restoring the terrain. They build a **body that cancer cannot easily inhabit** — not through vigilance or fear, but through alignment with [[Glossary of Terms#Logos|Logos]]. The protocols on this wheel, faithfully executed, create an environment hostile to malignancy — metabolically flexible and immunologically vigilant, its inflammation resolved and its toxic burden cleared. This is not a guarantee — reality is complex and probabilistic — but it is the highest-leverage approach available. And it carries an additional virtue: the same interventions that prevent cancer simultaneously prevent cardiovascular disease, neurodegeneration, metabolic dysfunction, and the entire cascade of chronic inflammatory conditions. Health, at its root, is coherent.

---

*See also: [[Wheel of Health]], [[Inflammation-Chronic-Disease|Inflammation & Chronic Disease]], [[Purification]], [[Nutrition]], [[Monitor]], [[Supplementation]], [[Recovery]], [[Sleep]], [[Prostate-Health]], [[Health-Longevity-Biggest-Levers|Biggest Levers]], [[Fat-Loss-Protocol|Fat Loss]], [[The First 90 Days]]*
